Effective Inhibition of Xenografts of Hepatocellular Carcinoma (HepG2) by Rapamycin and Bevacizumab in an Intrahepatic Model

PURPOSE: Hepatocellular carcinoma (HCC) displays a characteristic hypervascularity and depends on angiogenesis for tumor growth, which thus provides a potential target for therapeutic approaches to HCC. In this study, through the use of combined micro-positron emission tomography (PET)/computed tomo...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Lai-Chun, Song, In-Chin, Jin, Yi, Kee, Irene H. C., Siew, Eeyan, Yu, Sidney, Thng, Choon-Hua, Huynh, Hung, Chow, Pierce K. H.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719751/
https://www.ncbi.nlm.nih.gov/pubmed/19330383
http://dx.doi.org/10.1007/s11307-009-0213-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2719751/
https://www.ncbi.nlm.nih.gov/pubmed/19330383
http://dx.doi.org/10.1007/s11307-009-0213-4

Ejemplares similares